Alignment Healthcare, Inc. $ALHC Shares Sold by Strs Ohio

Strs Ohio cut its stake in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) by 71.5% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 14,000 shares of the company’s stock after selling 35,100 shares during the quarter. Strs Ohio’s holdings in Alignment Healthcare were worth $244,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Inspire Investing LLC bought a new stake in shares of Alignment Healthcare during the 3rd quarter worth $1,129,000. Ameritas Investment Partners Inc. increased its stake in Alignment Healthcare by 32.9% in the 2nd quarter. Ameritas Investment Partners Inc. now owns 13,031 shares of the company’s stock worth $182,000 after purchasing an additional 3,225 shares in the last quarter. Schroder Investment Management Group raised its holdings in Alignment Healthcare by 28.7% during the 2nd quarter. Schroder Investment Management Group now owns 248,163 shares of the company’s stock worth $3,437,000 after buying an additional 55,314 shares during the period. Jump Financial LLC raised its holdings in shares of Alignment Healthcare by 173.8% during the second quarter. Jump Financial LLC now owns 1,056,600 shares of the company’s stock valued at $14,792,000 after acquiring an additional 670,750 shares during the period. Finally, Voya Investment Management LLC lifted its holdings in shares of Alignment Healthcare by 61.0% in the third quarter. Voya Investment Management LLC now owns 3,196,297 shares of the company’s stock valued at $55,775,000 after purchasing an additional 1,210,930 shares in the last quarter. 86.19% of the stock is currently owned by institutional investors and hedge funds.

Alignment Healthcare Trading Up 0.5%

Shares of ALHC opened at $22.65 on Tuesday. The stock’s fifty day simple moving average is $20.59 and its 200-day simple moving average is $17.57. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 1.99. The firm has a market capitalization of $4.53 billion, a PE ratio of -188.75, a price-to-earnings-growth ratio of 5.93 and a beta of 1.16. Alignment Healthcare, Inc. has a 12-month low of $11.63 and a 12-month high of $23.87.

Analysts Set New Price Targets

Several equities analysts recently commented on the stock. Weiss Ratings reiterated a “sell (d-)” rating on shares of Alignment Healthcare in a research note on Wednesday, January 21st. KeyCorp reaffirmed an “overweight” rating and set a $28.00 price objective on shares of Alignment Healthcare in a research report on Thursday, January 22nd. Robert W. Baird set a $28.00 target price on Alignment Healthcare in a research report on Friday. Wall Street Zen cut Alignment Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, January 17th. Finally, The Goldman Sachs Group reiterated a “buy” rating and issued a $22.00 price objective on shares of Alignment Healthcare in a research report on Monday, November 3rd. One analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Alignment Healthcare currently has an average rating of “Moderate Buy” and an average price target of $23.05.

Insiders Place Their Bets

In other news, insider Robert L. Scavo sold 69,541 shares of the business’s stock in a transaction on Monday, December 29th. The shares were sold at an average price of $18.74, for a total value of $1,303,198.34. Following the sale, the insider owned 503,014 shares of the company’s stock, valued at $9,426,482.36. The trade was a 12.15% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, President Dawn Christine Maroney sold 282,070 shares of the stock in a transaction dated Monday, December 29th. The stock was sold at an average price of $18.74, for a total transaction of $5,285,991.80. Following the transaction, the president owned 1,385,167 shares of the company’s stock, valued at approximately $25,958,029.58. This represents a 16.92% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 2,103,532 shares of company stock worth $40,529,538. Corporate insiders own 6.60% of the company’s stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.